Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea
The authors have withdrawn this manuscript because of the controversy about hydroxychloroquine and potential changes in results after peer-review, the authors intend to share their results in formal publication. Therefore, the authors do not wish this work to be cited as reference for the project. I...
| Autor principal: | |
|---|---|
| Formato: | Published Article |
| Publicado: |
2020-06-14
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1101/2020.05.13.20094193 https://hdl.handle.net/20.500.12663/1750 |